Financial statements Vitrolive
Balance sheet data of VITROLIVE
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 3 333 141,63 | 3 573 071,13 | 4 226 070,64 | 3 578 406,37 | 3 848 202,42 |
A. Fixed assets | 1 183 909,92 | 1 230 675,63 | 1 398 353,35 | 1 485 882,99 | 1 822 303,44 |
B. Current assets | 2 149 231,71 | 2 342 395,50 | 2 827 717,29 | 2 092 523,38 | 2 025 898,98 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 3 333 141,63 | 3 573 071,13 | 4 226 070,64 | 3 578 406,37 | 3 848 202,42 |
A. Equity | 2 575 867,27 | 2 637 125,34 | 2 764 230,59 | 825 190,83 | 1 178 430,34 |
B. Liabilities and provisions for liabilities | 757 274,36 | 935 945,79 | 1 461 840,05 | 2 753 215,54 | 2 669 772,08 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 562 685,75 | 750 831,60 | 736 504,87 | 826 635,08 | 1 245 235,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.